Literature DB >> 11677705

Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial.

E Watson1, A Clements, P Yudkin, P Rose, C Bukach, J Mackay, A Lucassen, J Austoker.   

Abstract

BACKGROUND: It has been suggested that primary care should become more involved in providing genetic services, such as basic risk assessment, to enable patients with a moderate/high risk to be referred and those with a low risk to receive reassurance and advice from their general practitioner (GP). However, GPs currently lack knowledge and confidence in this area. AIM: To investigate the effect of an in-practice educational session and information pack on GP management of familial breast/ovarian cancer cases. DESIGN OF STUDY: Cluster randomised controlled trial.
SETTING: GP principals in 170 practices in Oxfordshire and Northamptonshire. Of the 688 GPs, 426 (62%) participated.
METHOD: Practices were randomised either to Group A (receiving an inpractice educational session plus information pack), Group B (receiving an information pack alone), or Group C (receiving neither an educational session nor a pack). The main study outcome was the proportion of GPs making the correct referral decision on at least five out of six family history vignettes. A secondary outcome was GPs' reported confidence in managing patients with a family history of breast/ovarian cancer, measured by a score that was generated by combining responses to four questions.
RESULTS: There was a 40% (95% CI = 30-50%, P < 0.001) improvement in the proportion of GPs who made the correct referral decision on at least five out of the six vignettes in Group A (111/140 [79%]) compared with Group C (controls) (63/162 [39%]), and a 42% (95% CI = 31-52%, P < 0.001) improvement in Group B (100/124 [81%]) compared with the control group. There was a trend in reported confidence in the management of individuals with a family history of breast/ovarian cancer from a mean confidence score of 2.3 in Group A to 2.0 in Group B and 1.5 in Group C (P < 0.001).
CONCLUSION: Providing GPs with an information pack significantly improved referral decisions regarding patients with a family history of breast/ovarian cancer. Although extremely well received, an in-house educational session produced no additional improvements. There were, however, greater levels of reported confidence in the group who received the educational session in addition to the information pack.

Entities:  

Mesh:

Year:  2001        PMID: 11677705      PMCID: PMC1314127     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  16 in total

1.  The 'new genetics' and primary care: GPs' views on their role and their educational needs.

Authors:  E K Watson; D Shickle; N Qureshi; J Emery; J Austoker
Journal:  Fam Pract       Date:  1999-08       Impact factor: 2.267

2.  Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases.

Authors:  A Lucassen; E Watson; J Harcourt; P Rose; J O'Grady
Journal:  Fam Pract       Date:  2001-04       Impact factor: 2.267

3.  Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

Authors:  D M Eccles; D G Evans; J Mackay
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

4.  Analysis of cluster randomized trials in primary care: a practical approach.

Authors:  M K Campbell; J Mollison; N Steen; J M Grimshaw; M Eccles
Journal:  Fam Pract       Date:  2000-04       Impact factor: 2.267

5.  Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action).

Authors:  M Campbell; J Grimshaw; N Steen
Journal:  J Health Serv Res Policy       Date:  2000-01

6.  GPs' views on their role in cancer genetics services and current practice.

Authors:  A Fry; H Campbell; H Gudmunsdottir; R Rush; M Porteous; D Gorman; A Cull
Journal:  Fam Pract       Date:  1999-10       Impact factor: 2.267

Review 7.  Implementing guidelines in general practice care.

Authors:  R Grol
Journal:  Qual Health Care       Date:  1992-09

8.  Randomized controlled trial of the effect of the Royal College of Radiologists' guidelines on general practitioners' referrals for radiographic examination.

Authors:  P Oakeshott; S M Kerry; J E Williams
Journal:  Br J Gen Pract       Date:  1994-05       Impact factor: 5.386

9.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

10.  A study of GP referrals to a family cancer clinic for breast/ovarian cancer.

Authors:  E Watson; J Austoker; A Lucassen
Journal:  Fam Pract       Date:  2001-04       Impact factor: 2.267

View more
  21 in total

1.  Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

Authors:  A Niroshan Siriwardena; Aly Rashid; Mark R D Johnson; Michael E Dewey
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

2.  Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study.

Authors:  Peter W Rose; Michael Murphy; Marcus Munafo; Cyril Chapman; Neil Mortensen; Anneke Lucassen
Journal:  Br J Gen Pract       Date:  2004-04       Impact factor: 5.386

3.  Family physician self-efficacy with screening for inherited cancer risk.

Authors:  Robert Gramling; Justin Nash; Karen Siren; Charles Eaton; Larry Culpepper
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

4.  Interactive genetic counseling role-play: a novel educational strategy for family physicians.

Authors:  Sean M Blaine; June C Carroll; Andrea L Rideout; Gord Glendon; Wendy Meschino; Cheryl Shuman; Deanna Telner; Natasha Van Iderstine; Joanne Permaul
Journal:  J Genet Couns       Date:  2008-01-30       Impact factor: 2.537

5.  Identification of familial clustering for cancer through the family health strategy program in the municipality of Angra dos Reis, Rio de Janeiro, Brazil.

Authors:  Daniela Koeller Rodrigues Vieira; Margareth Attianezi; Ana Carolina Esposito; Anneliese Barth; Cecília Sequeira; Nathália Krause; Vivian Oliveira; Alexandre Lucidi; Cassio Serao; Juan C Llerena
Journal:  J Community Genet       Date:  2014-07-26

6.  Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations.

Authors:  Marta M Reis; Dorothy Young; Lorna McLeish; David Goudie; Alan Cook; Frank Sullivan; Helen Vysny; Alison Fordyce; Roger Black; Manouche Tavakoli; Michael Steel
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

7.  Assessing the effectiveness of a Grand Rounds CME activity for health-care professionals.

Authors:  Terry Ann Glauser; P Holder Nevins; J Chad Williamson; Brian Tomlinson
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

Review 8.  Referral interventions from primary to specialist care: a systematic review of international evidence.

Authors:  Lindsay Blank; Susan Baxter; Helen Buckley Woods; Elizabeth Goyder; Andrew Lee; Nick Payne; Melanie Rimmer
Journal:  Br J Gen Pract       Date:  2014-12       Impact factor: 5.386

9.  Efficacy of an educational intervention on family physicians' risk assessment and management of colorectal cancer.

Authors:  J C Carroll; S Blaine; J Permaul; E Dicks; E Warner; M J Esplen; H Rothenmund; K Semotiuk; G Worrall; J McLaughlin
Journal:  J Community Genet       Date:  2014-04-09

10.  Genetic education for primary care providers: improving attitudes, knowledge, and confidence.

Authors:  June C Carroll; Andrea L Rideout; Brenda J Wilson; Judith Md Allanson; Sean M Blaine; Mary Jane Esplen; Sandra A Farrell; Gail E Graham; Jennifer MacKenzie; Wendy Meschino; Fiona Miller; Preeti Prakash; Cheryl Shuman; Anne Summers; Sherry Taylor
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.